Quest Finds its Path to AI in Cancer Diagnostics Through M&A

Quest Finds its Path to AI in Cancer Diagnostics Through M&A

Source: 
Medical Devices and Diagnostics Industry
snippet: 
  • The deal is expected to be completed in 2Q24.
  • The deal includes PathAI Diagnostics' digitized laboratory, which will become Quest's AI & digital R&D and solutions center.